-
Company Profile
![]()
Adicet Bio Inc – Company Profile
Adicet Bio Inc (Adicet Bio), formerly resTORbio Inc, is a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and chimeric adaptors to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment...
Add to Basket -
Product Insights
![]()
Respiratory Tract Infections Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Respiratory Tract Infections Global Clinical Trials Review, H1, 2018" provides an overview of Respiratory Tract Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Respiratory Tract Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.